Your English writing platform
Discover LudwigSuggestions(1)
Exact(1)
Using a field strain, FST, also susceptible to TCBZ (Fig. 3b), the percentages of hatching were similar between concentrations, ranging from 19 to 29 %, being 33%% in the control well; no significant differences were shown between concentrations.
Similar(59)
MCT1 was present in well-oxygenated areas, but unexpectedly showed considerable expression in hypoxic areas as well (no significant difference, p = 0.11).
Consequently, the similar levels of available nutrients with NPK and MNPK treatments probably resulted in similar selection effects on AMF taxa, as well as no significant differences in diversity.
Given that miR-663 might influence the proliferation of hNSCs, we performed a BrdU incorporation assay as well; however, no significant differences were found (Supplementary Figure S5a and b).
The fiber bars were well tolerated and no significant differences were found for gastrointestinal tolerance.
The cohorts were well balanced with no significant differences between the two groups.
Table 3 shows that during baseline measurements both groups were well balanced with no significant differences between groups.
Both groups were well matched with no significant differences in demographics, histopathological parameters, tumour stage or location (Table 3).
The diet was well accepted, and no significant differences developed in body weight between the two diet groups.
Patient demographics and baseline PD characteristics were well matched, with no significant differences between groups (P > 0.05 for all) (Table 1).
Risedronate is taken daily, weekly, or (more recently) monthly and is generally well tolerated, with no significant differences in upper GI adverse events between those receiving placebo and risedronate [ 136, 143].
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com